International Journal of Clinical Pharmacy

, Volume 40, Issue 3, pp 668–675 | Cite as

Evaluation of community pharmacists’ knowledge and awareness of food–drug interactions in Palestine

  • Asma RadwanEmail author
  • Anwar Sweileh
  • We’am Shraim
  • Amr Hroub
  • Josephean Elaraj
  • Naser Shraim
Research Article


Background Food–drug interactions can produce undesirable outcomes during the therapy process. The pharmacist is responsible for providing patients counseling about common food-drug interactions. Knowledge of such interactions is important to avoid their occurrence. Objective This study aimed to assess the knowledge and awareness of community pharmacists about common food-drug interactions. Setting Pharmacists working in community pharmacies across Northern Palestine. Method This is a cross-sectional study, which involved a convenience sample of 259 pharmacists working in community pharmacies in Palestine. A self-administered questionnaire consisted of 29 questions (mainly yes/no questions) was used to assess pharmacists’ knowledge towards the most common and clinically significant interactions between food and medicines. Main outcome measure Pharmacists’ issues related to the knowledge of food drug interactions were evaluated. Results A total of 320 questionnaires were distributed of which 259 were completed providing a response rate 80.9%. One pharmacist from each community pharmacy was asked to complete the questionnaire. The overall knowledge score of food-drug interactions for the pharmacists was 17.9 (61.7%) out of a possible maximum of 29. The pharmacists surveyed in this study have demonstrated good knowledge of some interactions; but poor knowledge of others. Conclusion Pharmacists’ knowledge about common food–drug interactions is inadequate. These findings support the need for training and educational courses for pharmacists regarding food–drug interactions.


Community pharmacists Drug interactions Food–drug interactions Knowledge Palestine 



No external funding was received for this study.

Conflicts of interest

The authors declare no conflict of interest.


  1. 1.
    Schmidt LE, Dalhoff K. Food–drug interactions. Drugs. 2002;62:1481–502.CrossRefPubMedGoogle Scholar
  2. 2.
    Heininger-Rothbucher D, Bischinger S, Ulmer H, Pechlaner C, Speer G, Wiedermann CJ. Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation. 2001;49:283–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Straubhaar B, Krahenbuhl S, Schlienger RG. The prevalence of potential drug–drug interactions in patients with heart failure at hospital discharge. Drug Saf. 2006;29:79–90.CrossRefPubMedGoogle Scholar
  4. 4.
    Chatsisvili A, Sapounidis I, Pavlidou G, Zoumpouridou E, Karakousis VA, Spanakis M, Teperikidis L, Niopas I. Potential drug–drug interactions in prescriptions dispensed in community pharmacies in Greece. Pharm World Sci. 2010;32:187–93.CrossRefPubMedGoogle Scholar
  5. 5.
    Welling PG. Effects of food on drug absorption. Annu Rev Nutr. 1996;16:383–415.CrossRefPubMedGoogle Scholar
  6. 6.
    Kirby BJ, Unadkat JD. Grapefruit juice, a glass full of drug interactions? Clin Pharmacol Ther. 2007;81:631–3.CrossRefPubMedGoogle Scholar
  7. 7.
    Karlson B, Leijd B, Hellstrom K. On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment. Acta Med Scand. 1986;220:347–50.CrossRefPubMedGoogle Scholar
  8. 8.
    Johnson BF, Rodin SM, Hoch K, Shekar V. The effect of dietary fiber on the bioavailability of digoxin in capsules. J Clin Pharmacol. 1987;27:487–90.CrossRefPubMedGoogle Scholar
  9. 9.
    Jonkman JH, Sollie FA, Sauter R, et al. The influence of caffeine on the steady-state pharmacokinetics of theophylline. Clin Pharmacol Ther. 1991;49(3):248–55.CrossRefPubMedGoogle Scholar
  10. 10.
    Hung H, Peregrina AA, Rodriguez JM, Moreno-Esparza R. The influence of coffee with milk and tea with milk on the bioavailability of tetracycline. Biopharm Drug Dispos. 1997;18:459–63.CrossRefGoogle Scholar
  11. 11.
    Laitinen K, Patronen A, Harju P, Löyttyniemi E, Pylkkänen L, Kleimola T, Perttunen K. Timing of food intake has a marked effect on the bioavailability of clodronate. Bone. 2000;27:293–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Joint Commission on Accreditation of Health Care Organizations (PF1.5). Accreditation manual for hospitals: standards. AMH provision for counselling about drug–food interaction. JCAH Perspectives 1986, 1994.Google Scholar
  13. 13.
    Benni J, Jayanthi M, Tubaki B, Renuka M. Knowledge and awareness of food and drug interactions (FDI): a survey among health care professionals. Int J Pharmacol Clin Sci. 2012;1:97–105.Google Scholar
  14. 14.
    Enwerem NM, Okunji P. Knowledge, attitudes and awareness of food and drug interactions among nurses with different levels of experience. Int J Nurs. 2015;2:1–9.Google Scholar
  15. 15.
    Couris RR, Tataronis GR, Dallal GE, Blumberg JB, Dwyer JT. Assessment of healthcare professional’s knowledge about warfarin-vitamin K drug–nutrient interactions. J Am Coll Nutr. 2000;19:439–45.CrossRefPubMedGoogle Scholar
  16. 16.
    Lasswell AB, De Forge BR, Sobal J, Muncie HL, Michocki R. Family medicine resident’s knowledge and attitudes about drug–nutrient interactions. J Am Coll Nutr. 1995;14:137–43.CrossRefPubMedGoogle Scholar
  17. 17.
    Radwan A, Elaraj J, Zaid H, Ya’aqba M, Nour M, Jadallah H, Salamah R. Community pharmacists’ knowledge towards the proper dosing instructions and interactions of alendronate therapy. PMPJ. 2017;2:1–10.Google Scholar
  18. 18.
    Ghoneim M, Hinrichs JV, Chiang CK, Loke WH. Pharmacokinetic and pharmacodynamic interactions between caffeine and diazepam. J Clin Psychopharmacol. 1986;6:75–80.CrossRefPubMedGoogle Scholar
  19. 19.
    Lelawongs P, Barone JA, Colaizzi JL, Hsuan AT, Mechlinski W, Legendre R, et al. Effect of food and gastric acidity on absorption of orally administered ketoconazole. Clin Pharm. 1988;7(3):228–35.PubMedGoogle Scholar
  20. 20.
    Carmago SMR, Vuille-dit-Bille RN, MariottaL Ramadan T, Huggel K, Singer D, et al. The molecular mechanism of intestinal Levodopa absorption and its possible implications for the treatment of Parkinson’s disease. J Pharmacol Exp Ther. 2014;351:114–23.CrossRefGoogle Scholar
  21. 21.
    Blackwell B, Marley E, Price J, Taylor D. Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs. Br J Psychiatry. 1967;113:349–65.CrossRefPubMedGoogle Scholar
  22. 22.
    Sostek MB, Chen Y, Andersson T. Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole. Br J Clin Pharmacol. 2007;64:386–90.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Lacy C, Lora A, Goldman M. Drug information handbook 2002–2003. 11th ed. Hudson: Lexi-comp; 2002.Google Scholar
  24. 24.
    Ray K, Dorman S, Watson R. Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction. J Hum Hypertens. 1999;13:717–20.CrossRefPubMedGoogle Scholar
  25. 25.
    Morgan TO. Clinical use of potassium supplements and potassium sparing diuretics. Drugs. 1973;6:222–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Damle BD, Yan JH, Behr D, O’Mara E, Nichola P, Kaul S, et al. Effect of food on the oral bioavailability of didanosine from encapsulated enteric-coated beads. J Clin Pharmacol. 2002;42:419–27.CrossRefPubMedGoogle Scholar
  27. 27.
    Shyu WC, Knupp CA, Pittman KA, Dunkle L, Barbhaiya RH. Food-induced reduction in bioavailability of didanosine. Clin Pharmacol Ther. 1991;50:503–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Yeh KC, Deutsch PJ, HaddixH Hesney M, Hoagland V, Ju WD, et al. Single-dose pharmacokinetics of indinavir and the effect of food. Antimicrob Agents Chemother. 1998;42:332–8.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Lieber CS. Mechanisms of ethanol–drug–nutrition interactions. J Toxicol Clin Toxicol. 1994;32:631–81.CrossRefPubMedGoogle Scholar
  30. 30.
    Abbasi NM, Slamzadeh J, Hagebi G, Gilbert B. The role of clinical pharmacists in educating nurses to reduce drug–food interactions (absorption phase) in hospitalized patients. Iran J Pharm Res. 2011;10:173–7.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Asma Radwan
    • 1
    Email author
  • Anwar Sweileh
    • 1
  • We’am Shraim
    • 1
  • Amr Hroub
    • 1
  • Josephean Elaraj
    • 1
  • Naser Shraim
    • 1
  1. 1.Department of PharmacyAn-Najah National UniversityNablusPalestine

Personalised recommendations